Regulations.gov document
Prescription Drug Products; Digoxin Elixir; Extension to Obtain Marketing Approval
Notice · FDA-2000-N-0010 · posted Jun 29, 2004
Key facts
| Document ID | FDA-2000-N-0010-0002 |
|---|---|
| Title | Prescription Drug Products; Digoxin Elixir; Extension to Obtain Marketing Approval |
| Document type | Notice |
| Subtype | General Notice |
| Agency | FDA |
| Docket | FDA-2000-N-0010 |
| Posted | Jun 29, 2004 |
| Federal Register citation | 69 FR 38906 |
| FR document number | 04-14796 |
| Comment period opens | Jun 29, 2004 |
| Effective date | Jun 24, 2004 |
At a glance
- None Pages
- None Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: